1. |
Details of PDMR/person closely associated with them ('PCA') |
a) |
Name |
Mr B McNamara |
b) |
Position/status |
CEO, GSK Consumer Healthcare |
c) |
Initial notification/ amendment |
Initial notification |
2. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
a) |
Name |
GlaxoSmithKline plc |
b) |
LEI |
5493000HZTVUYLO1D793 |
3. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted |
a) |
Description of the financial instrument |
American Depositary Shares ('ADSs') ISIN: US37733W1053 |
b) |
Nature of the transaction |
Following the vesting on 2 March 2018 of an award made on 2 March 2015 under the GlaxoSmithKline Deferred Investment Award Plan, Mr McNamara will receive a cash payment of $684,709.84 less applicable tax withholding in respect of 18,967.031 notional ADSs. |
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
$36.10 |
18,967.031 |
|
d) |
Aggregated information Aggregated volume Price |
n/a (single transaction) |
e) |
Date of the transaction |
2018-03-02 |
f) |
Place of the transaction |
n/a |
